Amylyx looks to cover financial gap left by Relyvrio with avexitide deal, says GlobalData
The acquisition is a strategic action by Amylyx following the failure of its lead amyotrophic lateral sclerosis (ALS) therapy,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Wolfram syndrome
Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData
Amylyx explores new indications for Relyvrio after ALS trail setback, with early success in Wolfram syndrome and other…